-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Titan Pharmaceuticals Inc-On Jan 4, 2023 Received Notice Of Delisting Or Failure To Satisfy Continued Listing Transfer Of Listing From Nasdaq

Reuters · 01/06/2023 16:20
BRIEF-Titan Pharmaceuticals Inc-On Jan 4, 2023 Received Notice Of Delisting Or Failure To Satisfy Continued Listing Transfer Of Listing From Nasdaq

- Titan Pharmaceuticals Inc TTNP.O:

  • TITAN PHARMACEUTICALS INC-ON JAN 4, 2023 RECEIVED NOTICE OF DELISTING OR FAILURE TO SATISFY CONTINUED LISTING; TRANSFER OF LISTING FROM NASDAQ

Further company coverage: TTNP.O


((Reuters.Briefs@thomsonreuters.com;;))